Fosun International LTD Cure Vac N.V. Transaction History

Fosun International LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$13.18 - $19.41 $197,700 - $291,150	-15,000 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$14.73 - $35.25 $73,650 - $176,250	5,000 Added 50.0%	15,000 $290,000
Q4 2021 Feb 10, 2022	BUY	$33.72 - $48.22 $337,200 - $482,200	10,000 New	10,000 $337,000
Q2 2021 Aug 12, 2021	SELL	$56.91 - $127.53 $2.85 Million - $6.38 Million	-50,000 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$79.79 - $126.29 $3.99 Million - $6.31 Million	50,000 New	50,000 $4.44 Million

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $538M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.